In primary hepatocytes, we found that classical antidiabetic and insulin-sensitizer drugs, e.g., metformin and rosiglitazone, as well as micronutrients known to improve metabolism and obesity, e.g., the isoflavone genistein, specifically modulate the expression of these hepatokines. This evidence concerns the gene INS and Obesity.